Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Cairo University
The application of platelet concentrates characterized by high concentrations of platelets and growth factors have been applied and investigated as possible periodontal regenerative therapy. The application of platelet rich fibrin in management of intraosseous and furcation defects produce more favorable outcome compared to open flap debridement.
A-PRF+ represents the latest generation of platelet concentrates that could provide sustained and increased release of growth factors and could serve as an autologous cost-effective membrane in periodontal tissue regeneration procedures
Age
18–60
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Stage III periodontitis patient having at least one tooth with 2-wall, 3-wall, or combined 2- to 3-wall intraosseous defect ≥ 3 mm in depth (assessed by bone sounding, radiographic examination) with clinical attachment level (CAL) ≥ 5mm and pocket depth (PD) ≥ 6 mm.
Defect not extending to a root furcation area
Non-smokers.
No history of intake of medications affecting the periodontium in the previous 6 months.
Able to sign an informed consent form.
Patients age between 18 and 60 years old.
Patients who are cooperative, motivated, and hygiene conscious.
Systemically free according to Cornell Medical Index (Broadbent, 1951).